Carrick Therapeutics
Targeting aggressive cancer
Carrick Therapeutics has raised €86M across 1 funding round from 5 investors, most recently a Series A round in Oct 2016. Based in Dublin, Ireland; founded 2015; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€86M
€86,400,000
Funding rounds
1
Investors
5
distinct backers
Active since
2016-10
latest 2016-10
Funding by year
EUR raised per yearCarrick Therapeutics — funding by year — interactive chart.
Data table
| Carrick Therapeutics — funding by year | |
|---|---|
| 2016 | €86M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-10-01 | Series A | €86M | Cambridge Enterprise,Cambridge Innovation Capital,GV (Google Ventures),Lightstone Ventures,Woodford Investment Management | View deal → |
Investors
5Related news
Similar companies
same sector, similar size- Genomics Medicine Ireland€36MIreland · Healthtech
- Inflazome€56MIreland · Healthtech
- Nuritas€88MIreland · Healthtech
- Adaptimmune€79MUK · Healthtech
- Neurent Medical€84MIreland · Healthtech
- Aerska€51MIreland · Healthtech
Global coverage: FundingData